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Abstract
Background: The pandemic influenza A (H1N1) virus emerged during 2009 and has spread worldwide. This virus
can cause injuries to the lungs, liver, and heart. However, data regarding whether this influenza virus can affect
pancreatic islets are limited. We investigated the effects of influenza A (H1N1) pneumonia on fasting plasma
glucose (FPG) and islet function, and evaluated possible correlations between biochemical test results and the
severity of H1N1 pneumonia.
Methods: We performed a retrospective analysis of patients either diagnosed with or suspected of having H1N1
pneumonia who were admitted to our hospital in 2009. Possible associations between FPG levels and H1N1 virus
infection were assessed by logistic regression. Correlation and regression analyses were used to assess relationships
between FPG and biochemical test results. Associations between admission days and significant data were
assessed by single factor linear regression. To evaluate effects of H1N1 on pancreatic b-cell function, results of a
resistance index (homa-IR), insulin function index (homa-b), and insulin sensitivity index (IAI) were compared
between a H1N1 group and a non-H1N1 group by t-tests.
Results: FPG was significantly positively associated with H1N1 virus infection (OR = 1.377, 95%CI: 1.062-1.786; p =
0.016). FPG was significantly correlated with AST (r = 0.215; p = 0.039), LDH (r = 0.400; p = 0.000), BUN (r = 0.28;
p = 0.005), and arterial Oxygen Saturation (SaO2; r = -0.416; p = 0.000) in the H1N1 group. H1N1 patients who
were hypoxemic (SaO2<93%) had higher FPG levels than those who were not hypoxic (9.82 ± 4.14 vs. 6.64 ± 1.78;
p < 0.05). FPG was negatively correlated with SaO2 in the H1N1 group with hypoxia (SaO2<93; r = -0.497; p =
0.041). SaO2 levels in patients with high FPG levels (≥7 mmol/L) were significantly lower than those of H1N1
patients with low FPG levels (<5.6 mmol/L). There were no significant differences in homa-IR, homa-b, or IAI
between the H1N1 and non-H1N1 groups after adjusting for age, sex, and BMI.
Conclusions: FPG on admission could be an independent predictor for the severity of H1N1 pneumonia. Elevated
FPG induced by H1N1 pneumonia is not a result of direct damage to pancreatic b-cells, but arises from various
factors’ combinations caused by H1N1 virus infection.
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Background
The pandemic influenza A (H1N1) virus emerged in the
United States and Mexico last year and rapidly spread
worldwide [1,2]. Up to December 13, 2009, more than
208 countries and overseas territories or communities
have reported laboratory-confirmed cases of pandemic
influenza H1N1 2009, which has caused at least 10,582
deaths [3]. It has been indicated that this virus can
induce pulmonary complications, respiratory failure, and
liver and heart injuries. Diabetes, which is a major risk
factor for H1N1 infection, has been frequently observed
among severe cases and those who died [4-6]. However,
data regarding whether the influenza virus can affect the
plasma glucose level and islet function remain limited.
Based on the data from H1N1 cases in our hospital,
we decided to explore possible relationships between
fasting plasma glucose (FPG) levels, relevant laboratory
test findings, and the clinical course of H1N1 infection.
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damage on pancreatic b-cell function, we compared
changes of islet function between confirmed H1N1
patients and non-H1N1 patients.
Methods
Patients
Data were collected from suspected H1N1-infected
patients who had complications of pneumonia in the
Emergency Ward of the Second Hospital of Harbin
Medical University in 2009. The diagnostic criteria for
suspected H1N1, which were similar to those of the
Centers for Disease Control and Prevention (CDC) cri-
teria [7], were defined by the Chinese Ministry of
Health: fever, known exposure to H1N1, respiratory
symptoms, and infiltrates observed on chest radiography
[8]. Pharynx swab samples of all suspected cases were
sent to the provincial CDC, where H1N1 virus infection
was detected and confirmed by real time PCR.
In this retrospective analysis, the clinical and biochem-
ical characteristics of 34 patients positive for H1N1 and
67 patients with non-H1N1 pneumonia were compared.
Patients were excluded if they were younger than 16
years of age, were pregnant, had a history of diabetes, or
died. Data from laboratory examinations were collected
on admission and before steroid treatment, including
FPG, glycosylated hemoglobin (HBA1c), function tests
for liver and kidney, myocardial enzymes, blood cells,
and arterial blood gas analysis. Arterial oxygen satura-
tion (SaO2) < 93% (measured on supplemental oxygen)
was also used to classify cases as ‘serious’; the duration
of a hospital stay was the main indicator to judge sever-
ity of the disease. Plasma insulin (FINS) was randomly
tested among 21 H1N1-positive and 31 H1N1-negative
patients at the same time of FPG determinations.
To account for possible H1N1 effects on pancreatic b-
cell function, a homeostasis model assessment (Homa)
and IAI were used to measure insulin resistance and
sensitivity [9,10]. These included: an insulin resistance
index: Homa-IR = Ln(FPG × FINS/22.5); b-cell function
index: Homa-b = 20 × FINS/(FPG-3.5); and insulin sen-
sitivity index : IAI = -Ln(1/(FPG × FINS). This study
was approved by the Ethics Committee of the Harbin
Municipal Bureau of Health.
Treatments
Upon admission, all patient blood samples had been
screened with hematology, biochemistry, and virology
tests. All patients were empirically administrated antivir-
als, broad-spectrum antibiotics, and mechanical ventila-
tion therapy before certification of viral or bacterial
infections. Baseline and serial chest radiographs and CT
scans, if necessary, were performed for all suspected or
confirmed H1N1 patients. For suspected or confirmed
H1N1 patients with severe pneumonia, as indicated by
persistent fever and deteriorating lung opacities on chest
X-ray, intravenous therapy with methylprednisolone
(120-500 mg every day for 5 days followed by a decreas-
ing dose based on the patient’s condition) was used as
necessary treatment.
Statistical analysis
Results are given as means ± SDs or percentages and
compared between different groups by independent t-
tests or ANOVA, as appropriate. Associations between
FPG and H1N1 virus infection, expressed as Odds
Ratios (OR) and 95% confidence intervals (CI), were
examined by logistic regression analysis after controlling
for sex, age, and BMI. Correlation analysis was used to
evaluate possible relationships between FPG and bio-
chemical test results. Associations between number of
admission days and significant data among the two
groups were further assessed by single factor linear
regression. Associations between FPG and SaO2 were
assessed by correlation and regression analyses. To eval-
uate possible H1N1 effects on pancreatic b-cell function,
homa-IR, homa-b,a n dI A Iw e r ec o m p a r e db yt-tests
between H1N1 and non-H1N1 groups after adjusting
for age, gender, and BMI. All analyses used SPSS version
13.0 (SPSS Inc., Chicago, IL, USA). P < 0.05 (two-tailed)
was considered to be statistically significant.
Results
1. Comparisons of clinical features between H1N1 and
non-H1N1 pneumonia patients
All data for the patients diagnosed as suspected H1N1
and confirmed H1N1 were collected in the Emergency
Ward of the Second Hospital of Harbin Medical Univer-
sity in 2009. All patients were Han Chinese, except for
one Man Chinese, and all were from Harbin City or sur-
rounding areas. Table 1 summarizes the clinical and
biochemical characteristics of the H1N1 and non-H1N1
patients. There were no statistically significant differ-
ences for age, gender, or BMI between the two groups.
There were no detectable differences in WBC counts
and differential counts, and hepatic and renal functions
between the two groups.
However, significant differences of biochemical exam
results were found in plasma glucose levels (7.93 ± 3.44
v s .6 . 1 3±1 . 5 4 ,H 1 N 1v s .n o n - H 1 N 1 ;p<0 . 0 1 ) ,L D H
(1139.63 ± 1086.24 vs. 501.59 ± 613.70, H1N1 vs. non-
H1N1; p < 0.01), BUN (6.57 ± 4.46 vs. 4.54 ± 2.42,
H1N1 vs. non-H1N1; p < 0.05), and SaO2 (86.29 ±
13.23 vs. 93.23 ± 7.30, H1N1 vs. non-H1N1; P < 0.05).
The number of admission days for H1N1 patients were
obviously longer than for non-H1N1 patients (17.65 ±
8.28 vs. 11.91 ± 8.77, H1N1 vs. non-H1N1; p < 0.01).
Logistic regression analysis indicated significant positive
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1.786; p = 0.016), LDH (OR = 1.001, 95%CI: 1.000-
1.002; p = 0.010), BUN (OR = 1.184, 95%CI: 1.024-
1.369; p = 0.022) and H1N1 virus infection.
2. Relationship between FPG and H1N1
Defining SaO2 of 93% as a threshold, we further investi-
gated the relationship between FPG and SaO2.T h o s e
with high FPG levels (≥7 mmol/L) had a significantly
lower SaO2 level than those with low FPG levels (<5.6
mmol/L) among H1N1 patients (Figure 1). The associa-
tion between FPG and SaO2 is shown in Figure 2. In the
H1N1 group, patients with hypoxia (SaO2< 93%) had
remarkably higher FPG levels than those of patients
with SaO2 ≥ 93% (Table 2). Elevated FPG also paralleled
a trend for prolonged hospitalization, although there
was no correlation between FPG and hospitalization
duration (data not shown). Figure 3 shows the relation-
ships between FPG levels and other biochemical indica-
tors in the H1N1 group. Significant Pearson correlation
coefficients were found between FPG and AST (r =
0.215; p = 0.039), LDH (r = 0.400; p = 0.000), BUN (r =
0.28; p = 0.005), and SaO2 (r = -0.416; p = 0.000).
3. Influence of H1N1 infection on pancreatic islets
function
Random determinations of FPG and FINS were made
for suspected H1N1 patients on admission; information
was collected for 21 confirmed-H1N1 patients and 34
non-H1N1 patients. The possible effects of H1N1 on
pancreatic islets function was evaluated by calculating
Table 1 Clinical and laboratory Data of study subjects
Patient with non-H1N1 pneumonia
(n = 67)
Patients with confirmed H1N1
pneumonia (n = 34)




Age (years) 33.70 ± 13.32 37.76 ± 12.59
Male (%) 53.7 55.9
BMI 24.98 ± 4.75 24.54 ± 3.69
Duration of hospitalization
(days)
11.91 ± 8.77 17.65 ± 8.28**
Mechanical ventilation(no.) 12 18
Excluded patient(no.) 4 7
Pregnant women 1 3
Diabetes of history 3 2
Death 0 2
White cell count (×10
9/L) 7.89 ± 5.90 8.84 ± 5.95 1.011(0.984-1.040) 0.417
Neutrophils (×10
9/L) 4.67 ± 2.78 5.86 ± 3.68 1.121(0.938-1.339) 0.208
Lymphocytes (×10
9/L) 1.16 ± 0.56 0.87 ± 0.63 0.367(0.120-1.121) 0.078
Monocytes (×10
9/L) 0.51 ± 0.32 0.42 ± 0.36 0.358(0.058-2.205) 0.268
ALT (U/L) 81.53 ± 139.48 53.39 ± 43.59 0.997(0.990-1.003) 0.309
AST (U/L) 102.54 ± 183.13 122.82 ± 145.68 1.000(0.998-1.003) 0.704
CK (U/L) 190.68 ± 225.53 345.86 ± 635.14 1.001(1.000-1.002) 0.079
CK-MB (U/L) 22.32 ± 18.81 19.55 ± 13.30 0.995(0.953-1.038) 0.811
LDH (U/L) 501.59 ± 613.70 1139.63 ± 1086.24** 1.001(1.000-1.002) 0.010*
BUN (μmol/L) 4.54 ± 2.42 6.57 ± 4.46* 1.184(1.024-1.369) 0.022*
CREA (μmol/L) 76.93 ± 35.19 92.97 ± 52.57 1.009(0.998-1.019) 0.119
FPG (mmol/L) 6.13 ± 1.54 7.93 ± 3.44** 1.377(1.062-1.786) 0.016*
PO2 (mmHg) 79.42 ± 31.73 70.29 ± 36.53 1.003(0.985-1.021) 0.729
PCO2 (mmHg) 37.10 ± 4.79 35.86 ± 5.20 0.948(0.856-1.046) 0.280
SaO2 (%)
& 93.23 ± 7.30 86.29 ± 13.23* 1.045(0.976-1.118) 0.205
*p < 0.05; **p < 0.01, vs. non-H1N1 patients; *significant exam associated with H1N1 infection assessed by logistic regression after controlling age, sex and BMI.
The data expressed as mean ± SD, or percentage, or OR and 95%CI
Figure 1 The comparison of SaO2 among different levels of
FPG in H1N1 group *, p < 0.05.
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tion index(homa-b), and an insulin sensitivity index
(IAI). The mean FPG level was significantly higher in
t h eH 1 N 1g r o u p( 8 . 2 9±3 . 5 7v s .6 . 2 2±1 . 6 2 ,H 1 N 1v s .
non-H1N1; p < 0.05; Table 3). However, no statistically
significant differences were found for homa-IR, homa-b,
or IAI between the H1N1 and non-H1N1 groups after
adjusting for age, gender, and BMI (Table 3).
4. Predictors for the severity and clinical course of H1N1
In the H1N1 group, the FPG levels of patients with
hypoxemia (SaO2 <93%) were higher than those of
patients without hypoxia (9.82 ± 4.14 vs. 6.64 ± 1.78; p
< 0.05; Table 2). After adjusting for age, gender, and
BMI, a significant negative correlation was found
between FPG levels and SaO2 in the H1N1 group with
SaO2 < 93%(r = -0.497; p = 0.041). The mean course of
H1N1 patients with SaO2 ≥ 93% was 12.26 ± 7.63 d,
whereas for patients with SaO2<9 3% it was 19.22 ±
11.15 d; there was a significant difference between the 2
groups (p < 0.05). In addition to FPG, some biochemical
indicators that might influence or predict the disease
course were analyzed by linear regression analysis.
These results showed that number of hospitalization
days were correlated with LDH (b = 0.000297 ± 0.0000;
p = 0.049), BUN (b = 0.0891 ± 0.036; p = 0.013), PaO2
(b = -0.0119 ± 0.004; p = 0.003), and SaO2 (b = -0.0287
± 0.013; p = 0.036).
Discussion
Since the global outbreak of H1N1 in 2009, a large
number of patients have died of H1N1 complications.
This virus can not only cause severe pneumonia and
respiratory failure, but can also impair the myocardium,
and hepatic and renal functions and can even lead to
multiple organ failure (MOF) [11,12]. However, there
have been no reports regarding whether H1N1 virus can
affect pancreatic b-cells. In this paper, we retrospectively
analyzed suspected and confirmed H1N1 cases and
found that the FPG level of H1N1 patients on admission
was an important and independent predictor for the
severity of H1N1.
It has been reported that diabetes mellitus (DM) is an
independent risk factor for H1N1 infection and that the
mortality of H1N1 patients complicated with DM is
much higher [4,5,13]. In our study, those H1N1 patients
with a diabetic history or pregnancy were excluded so as
to remove possible interference on FPG levels. For simi-
lar reasons, those cases that died were also excluded to
remove confounding effects from the statistical analysis.
Most of the patients in our study were cured and dis-
charged after appropriate therapies, except for 2 cases
that died.
Homa-IR, homa-b, and IAI are three important for-
mulas for analyzing pancreatic b-cells function, and
are widely used in the statistical analysis of clinical or
basic research. They represent, respectively, insulin
resistance, pancreatic b-cells function, and insulin sen-
sitivity. Logistic regression analysis and t-tests both
demonstrated notable relationships between FPG
levels and H1N1 infection, and higher FPG levels in
the H1N1 group than those in the non-H1N1 group.
However, H1N1 pneumonia did not affect Homa-IR,
homa-b, and IAI, which indicated that the H1N1 virus
might not directly damage pancreatic b-cells function,
and the elevated FPG levels in the H1N1 group might
be an indirect result. In contrast, the trend for down-
regulated homa-b in the H1N1 group (Table2) indi-
cates that H1N1 could potentially damage pancreatic
b-cells.
Correlation analysis for H1N1 patients showed clear
positive correlations between FPG and LDH, BUN and
Figure 2 The relationship between FPG and SaO2 among H1N1
and non-H1N1 group evaluated by scatter graph.
Table 2 Association between FPG and SaO2 among H1N1 and non-H1N1 patients with pneumonia
SaO2≧93% SaO2<93%
FPG (mmol/L) Hospitalization (days) FPG (mmol/L) Hospitalization (days)
H1n1 group (n = 34) 6.64 ± 1.78 12.26 ± 7.63 9.82 ± 4.14** 19.22 ± 11.15*
Non-H1N1 group (n = 67) 6.02 ± 0.96 11.52 ± 10.88 7.81 ± 3.30 12.11 ± 7.56
*P < 0.05 vs.SaO2≧93% group; *significant negative correlation with SaO2
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tion between FPG and SaO2. These results indicated
changes in inflammation, renal function, hepatic func-
tion, and pulmonary function. We speculate that H1N1-
mediated elevations of FPG might be the result of multi-
ple factors’ combinations caused by H1N1 virus infec-
tion, such as inflammatory stress, multiple organ
impairment, and so on, while the changes of plasma glu-
cose were not caused by H1N1 actions on insulin secre-
tion by pancreatic b-cells or decreasing sensitivity to
insulin.
To investigate the relationship between FPG and the
severity of H1N1 pneumonia, we used SaO2 on admis-
sion and the hospitalization course as indicators. We set
FPG of <5.6 mmol/L or ≥ 7 mmol/L as cut-off values
for low and high FPG, respectively. According to the
Chinese Ministry of Health criteria, hypoxia was defined
as SaO2 < 93%, probably resulting from diffuse alveolar
damage caused by H1N1 infection. In patients with
obvious hypoxia (SaO2 < 93%), there was a significantly
negative correlation between FPG and SaO2,i n d i c a t i n g
that FPG could be a predictor of severity in H1N1
patients with severe hypoxic conditions. Our results
showed that FPG was not a predictor for the number of
hospitalization days, although elevated FPG levels and a
prolonged stay in the hospital were in parallel. Thus, we
consider that the FPG level on admission is a
preliminary and feasible indicator for predicting the
severity of H1N1 pneumonia.
The H1N1 virus can cause damage to the body in
various ways. In addition to extensive pulmonary
inflammation and striking respiratory failure, it can
also impair multiple organ systems [14,15]. Our results
provide evidence that the myocardium, liver and kid-
neys are involved in H1N1 virus infection, as the myo-
cardial enzymes, aminotransferases, and creatinine
were elevated. Nevertheless, using the number of
admission days as an indicator of the severity of H1N1
pneumonia, only LDH, BUN, PaO2,a n dS a O 2 were
suitable for assessing disease duration. These results
indicated that FPG could not be used to predict the
clinical course of H1N1 in the hospital, but could be
used as a preliminary predictor for the severity of
H1N1 infection.
However, our study has some limitations. 1. An ele-
vated FPG level could be due to multiple factors in
H1N1 patients, whereas we only analyzed the associa-
tions between FPG and biochemical indicators; 2.We
did not determine correlations between pneumonia
scoring systems and FPG levels; and 3. The limited data
in our study requires additional verification.
Conclusions
In this paper, we retrospectively analyzed cases of sus-
pected and confirmed H1N1 infections in our hospital,
and indicated the importance of FPG for evaluating the
severity of H1N1 infection. Previous reports did not
indicate whether the H1N1 virus had an influence on
pancreatic b-cells function. Our results demonstrated
that elevated FPG induced by H1N1 pneumonia could
n o tb ear e s u l to fd i r e c td a m a g et op a n c r e a t i cb-cells,
but could arise from various factors’ combinations
caused by H1N1 virus infection. The FPG level of H1N1
patients on admission is a simple and feasible indicator
to predict the disease tendency; however, more informa-
tion and clinical data are required to investigate whether
the prognosis of H1N1 pneumonia will benefit from
plasma glucose control and regulation.
Figure 3 Correlation analysis between FPG and biochemical
exams among H1N1 patients. *significant correlation with FPG.
Table 3 Comparison of blood glucose levels and pancreatic b-cells function between H1N1 and non-H1N1 patients
Patient with non-H1N1 pneumonia (n = 31) Patients with confirmed H1N1 pneumonia (n = 21)
FBG (mmol/L) 6.22 ± 1.62 8.29 ± 3.57*
FINS(μU/mL) 15.07 ± 6.72 14.96 ± 6.70
HbA1c (%) 5.83 ± 0.60 6.22 ± 1.78
Homa-IR 4.12 ± 1.98 5.27 ± 3.88
Homa-b 134.73 ± 76.76 103.13 ± 82.37
IAI 4.42 ± 0.49 4.61 ± 0.55
*P < 0.05 vs. non-H1N1 patients after controlling age, sex and BMI
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